Chronic hepatitis B prevalence among Aboriginal and Torres Strait Islander Australians since universal vaccination: A systematic review and meta-analysis

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Graham, Simon ^a   Guy, Rebecca J ^a   Cowie, Benjamin ^b,c,d   Wand, Handan C ^a   Donovan, Basil ^a,e   Akre, Snehal P ^a   Ward, James S ^f  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e SYDNEY EYE HOSPITAL   (Australia)

^f BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

HBV; Hepatitis; Indigenous; Sexually transmissible infection; STI

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ABORIGINE; AGE DISTRIBUTION; ARTICLE; AUSTRALIA; HEALTH DISPARITY; HEPATITIS B; HUMAN; META ANALYSIS; PACIFIC ISLANDER; PREGNANT WOMAN; PREVALENCE; PRISONER; SYSTEMATIC REVIEW; VACCINATION;

AUSTRALIA; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B, CHRONIC; HUMANS; VACCINATION;

EID: 84883193702     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-403     Document Type: Article

References (56)

1. Centers for Disease Control and Prevention Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR 2008, 57(No. RR-8):1-3. Centers for Disease Control and Prevention.
2. World Health Organization Hepatitis B World Health Organization factsheets 2008 2010, Geneva: World Health Organization, World Health Organization.
3. Marianne G, Amany Z. National history of chronic hepatitis B virus infection. B Positive-all you wanted to know about hepatitis B: a guide for primary care providers 2008, Darlinghurst: Australasian Society for HIV Medicine Inc and The Cancer Council; NSW, Matthews G, Robotin M.
4. Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein ST, Wang SA, Moyer LA, Bell BP, Alter MJ. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of Infants, children, and adolescents. MMWR Recomm Rep 2005, 54(RR-16):1-31.
5. Blumberg BS, Alter HJ, Visnich S. A " New" antigen in leukemia sera. JAMA 1965, 191:541-546. 10.1001/jama.1965.03080070025007, 14239025.
6. World Health Organization WHO position paper: hepatitis B vaccines: weekly epidemiological record 2009, 405-420. Geneva: World Health Organization, World Health Organization.
7. MacLachlan JH, Allard N, Towell V, Cowie BC. The burden of chronic hepatitis B virus infection in Australia, 2011. Aust NZ J Public Health 2013, http://onlinelibrary.wiley.com/doi/10.1111/1753-6405.12049/pdf.
8. Australian Government Department of Health and Ageing National hepatitis B strategy 2010-2013 2010, Canberra: Commonwealth of Australia, Australian Government Department of Health and Ageing.
9. Fisher DA, Huffam SE. Management of chronic hepatitis B virus infection in remote-dwelling Aboriginals and Torres Strait Islanders: an update for primary healthcare providers. Med J Aust 2003, 178(2):82-85.
10. Australian Government Department of Health and Ageing Part 4: Vaccine-preventable diseases: hepatitis B. The Australian Immunisation Handbook 2013, 208-230. Canberra: Commonwealth of Australia, 10, Australian Government Department of Health and Ageing.
11. Dore G, Wallace J, Locarnini S, et al. Hepatitis B in Australia: responding to a diverse epidemic 2009, Sydney: ACT-HBV Australia and New Zealand Local Chapter of the Initiative in the Asia Pacific Region.
12. Liu B, Guthridge S, Li SQ, Markey P, Krause V, McIntyre P, Sullivan E, Ward J, Wood N, Kaldor JM. The end of the Australia antigen? An ecological study of the impact of universal newborn hepatitis B vaccination two decades on. Vaccine 2012, 30(50):7309-7314. 10.1016/j.vaccine.2012.09.033, 23036497.
13. Carville KS, Cowie BC. Recognising the role of infection: preventing liver cancer in special populations. Cancer Forum 2012, 36(1):21-24.
14. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004, 11(2):97-107. 10.1046/j.1365-2893.2003.00487.x, 14996343.
15. MacLachlan JH, Cowie BC. Liver cancer is the fastest increasing cause of cancer death in Australians. MJA 2012, 197(9):492-493.
16. Cunningham J, Rumbold AR, Zhang X, Condon JR. Incidence, aetiology, and outcomes of cancer in Indigenous peoples in Australia. Lancet Oncol 2008, 9(6):585-595. 10.1016/S1470-2045(08)70150-5, 18510990.
17. Kirby Institute Bloodborne viral and sexually transmitted infections in Aboriginal and Torres Strait Islander people: surveillance and evaluation report 2012 2012, Sydney NSW: Kirby Institute, the University of New South Wales, Kirby Institute.
18. Australian Institute of Health and Welfare The health and welfare of Australia's Aboriginal and Torres Strait Islander people: an overview. Cat. no. IHW 42 2011, Canberra: AIHW: Australian Institute of Health and Welfare, Australian Institute of Health and Welfare.
19. Vermund SH. Prevention of mother-to-child transmission of HIV in Africa. Top HIV Med 2004, 12(5):130-134.
20. Department of Vaccines and Biologicals: World Health Organisation Introduction of hepatitis B vaccine into childhood immunization services: management guidelines, including information for health workers and parents 2001, Geneva: World Health Organization, Department of Vaccines and Biologicals: World Health Organisation.
21. National Aboriginal Community Controlled Health Organisation and Royal Australian College of General Practitioners Chapter 8: Sexual health and bloodborne viruses. National Aboriginal guide to preventive health assessment for Aboriginal and Torres Strait Islander people 2012, 40-43. South Melbourne: Royal Australian College of General Practitioners, 2, National Aboriginal Community Controlled Health Organisation and Royal Australian College of General Practitioners.
22. Kaldor JM, Plant AJ, Thompson SC, Longbottom H, Rowbottom J. The incidence of hepatitis B infection in Australia: an epidemiological review. Med J Aust 1996, 165(6):322-326.
23. Australian Bureau of Statistics Experimental estimates and projections, Aboriginal and Torres Strait Islander Australians, 1991 to 2021 2006, Canberra: Commonwealth of Australia, Australian Bureau of Statistics.
24. Australian Bureau of Statistics 2012 year book Australia: a comprehensive source of information about Australia 2013, 92. Canberra: Commonwealth of Australia, ABS catalogue No.1301.0, Australian Bureau of Statistics.
25. Australian Bureau of Statistics The Australian Standard Geographical Classification (ASGC) 2011, Commonwealth of Australia, ABS catalogue No. 1216.0., Australian Bureau of Statistics.
26. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009, 151:264-269. 10.7326/0003-4819-151-4-200908180-00135, 19622511.
27. Brown LD, Cai TT, DasGupta A. Interval estimation for a binomial proportion. Stat Sci 2001, 16:101-133.
28. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controll Clin Trials 1986, 7(3):177-188.
29. Barrett EJ. Hepatitis-associated antigen in aboriginal groups in Northern Australia. Med J Aust 1972, 2(9):472-474.
30. Barrett EJ. Hepatitis B in Australian aborigines and Torres Strait Islanders: geographical, age and familial distribution of antigen subtypes and antibody. Aust N Z J Med 1976, 6(2):106-111. 10.1111/j.1445-5994.1976.tb03300.x, 14615.
31. Burrell CJ, Cameron AS, Hart G, Melbourne J, Beal RW. Hepatitis B reservoirs and attack rates in an Australian community: a basis for vaccination and cross infection policies. Med J Aust 1983, 2(10):492-496.
32. Campbell DH, Sargent JW, Plant AJ. The prevalence of markers of infection with hepatitis B virus in a mixed-race Australian community. Med J Aust 1989, 150(9):489-492.
33. Moore DJ, Bucens MR, Holman CD, Ott AK, Wells JI. Prenatal screening for markers of hepatitis B in aboriginal mothers resident in non-metropolitan Western Australia. Med J Aust 1987, 147(11-12):557-558.
34. Holman CD, Quadros CF, Bucens MR, Reid PM. Occurrence and distribution of hepatitis B infection in the aboriginal population of Western Australia. Aust N Z J Med 1987, 17(5):518-525. 10.1111/j.1445-5994.1987.tb00113.x, 3446164.
35. Gill JS, Bucens M, Hatton M, Carey M, Quadros CF. Markers of hepatitis B virus infection in schoolchildren in the Kimberley, Western Australia. Med J Aust 1990, 153(1):34-37.
36. Campbell DH, Plant AJ, Sargent JW, Mock PA, Barrett ER, Archer KH. Hepatitis B infection of children in a mixed-race community in western New South Wales. Med J Aust 1991, 154(4):253-256.
37. Patterson F, Bumak J, Batey R. Changing prevalence of hepatitis B virus in urbanized Australian aborigines. J Gastroenterol Hepatol 1993, 8(5):410-413. 10.1111/j.1440-1746.1993.tb01539.x, 8218988.
38. Gardner ID, Wan X, Simms PA, Worswick DA, Burrell CJ, Mathews JD. Hepatitis B virus markers in children and staff in Northern territory schools. Med J Aust 1992, 156(9):638-641.
39. Malcolm RL, Ludwick L, Brookes DL, Hanna JN. The investigation of a 'cluster' of hepatitis B in teenagers from an indigenous community in North Queensland. Aust N Z J Public Health 2000, 24(4):353-355. 10.1111/j.1467-842X.2000.tb01591.x, 11011457.
40. Panaretto KS, Lee HM, Mitchell MR, Larkins SL, Manessis V, Buettner PG, Watson D. Prevalence of sexually transmitted infections in pregnant urban Aboriginal and Torres Strait Islander women in northern Australia. Aust N Z J Obstet Gynaecol 2006, 46(3):217-224. 10.1111/j.1479-828X.2006.00577.x, 16704476.
41. Wood N, Warlow M, Quinn H, Selvey C, Lum G, McIntyre P, Kaldor J. Establishment of a surveillance system (utilising midwifes data collection systems) for monitoring the impact of hepatitis B vaccination on the population prevalence of chronic hepatitis B virus infection in Australia. Aust N Z J Public Health 2008, 32(3):272-275. 10.1111/j.1753-6405.2008.00228.x, 18578828.
42. Romanes F. Retrospective audit of immunoglobulin and vaccine uptake in infants at risk of perinatal transmission of hepatitis B virus. The NorthTerritory Disease Control Bulletin 2006, 13(1):15-20.
43. Schultz R. Hepatitis B screening among women birthing in Alice Springs hospital, and immunisation of infant at risk. The Northern Territory Disease Control Bulletin 2007, 14(2):1-5.
44. Schultz R, Romanes F, Krause V. Hepatitis B prevalence and prevention: antenatal screening and protection of infants at risk in the Northern territory. Aust N Z J Public Health 2008, 32(6):575-576. 10.1111/j.1753-6405.2008.00313.x, 19076752.
45. Poorten DVD, Kenny DT, George J. Prevalence of and risk factors for hepatitis C in Aboriginal and non-Aboriginal adolescent offenders. Med J Aust 2008, 188:610-614.
46. Templeton DJ, Tyson BA, Meharg JP, Habgood KE, Bullen PM, Malek S, McLean R. Aboriginal health worker screening for sexually transmissible infections and blood-borne viruses in a rural Australian juvenile correctional facility. Sex Health 2010, 7(1):44-48. 10.1071/SH09035, 20152095.
47. Gilles M, Swingler E, Craven C, Larson A. Prison health and public health responses at a regional prison in Western Australia. Aust N Z J Public Health 2008, 32(6):549-553. 10.1111/j.1753-6405.2008.00308.x, 19076747.
48. Carroll E, Davis JS. Incomplete hepatitis B screening prevents an adequate public health response in Aboriginal communities. Aust Indigenous Health Bull 2010, 10(4):1-8.
49. Carroll E, Page W, Davis JS. Screening for hepatitis B in East Arnhem land: a high prevalence of chronic infection despite incomplete screening. Intern Med J 2010, 40:784-791. 10.1111/j.1445-5994.2010.02316.x, 21155156.
50. Dent E, Selvey CE, Bell A, Davis J, McDonald MI. Incomplete protection against hepatitis B among remote Aboriginal adolescents despite full vaccination in infancy. Commun Dis Intell 2010, 34(4):435-439.
51. Robinson T, Bullen C, Humphries W, Hornell J, Moyes C. The New Zealand Hepatitis B screening programme: screening coverage and prevalence of chronic hepatitis B infection. N Z Med J 2005, 118(1211):U1345.
52. Ward J, Bryant J, Worth H, Hull P, Solar S, Bailey S. Use of health services for sexually transmitted and blood-borne viral infections by young Aboriginal people in New South Wales. Aust J Prim Health 2013, 19(1):81-86. 10.1071/PY11032, 22951105.
53. Papatheodoridis GV, Lampertico P, Manolakopoulos S, Lok A. Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review. J Hepatol 2010, 53(2):348-356. 10.1016/j.jhep.2010.02.035, 20483498.
54. Robotin MC, Kansil M, Howard K, George J, Tipper S, Dore GJ, Levy M, Penman AG. Antiviral therapy for hepatitis B-related liver cancer prevention is more cost-effective than cancer. J Hepatol 2009, 50(5):990-998. 10.1016/j.jhep.2008.12.022, 19303657.
55. Fung J, Gane E, McCall J. Improved survival with screening for hepatocellular carcinoma in chronic hepatitis B and liver cirrhosis. Hepatology 2005, 42(4):394a-394a.
56. Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 2004, 130(7):417-422.